These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 25234655)

  • 21. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 14: Sickle Cell Trait: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Maron BJ; Harris KM; Thompson PD; Eichner ER; Steinberg MH;
    Circulation; 2015 Dec; 132(22):e343-5. PubMed ID: 26527715
    [No Abstract]   [Full Text] [Related]  

  • 22. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 1: Classification of Sports: Dynamic, Static, and Impact: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Levine BD; Baggish AL; Kovacs RJ; Link MS; Maron MS; Mitchell JH
    J Am Coll Cardiol; 2015 Dec; 66(21):2350-2355. PubMed ID: 26542656
    [No Abstract]   [Full Text] [Related]  

  • 23. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 13: Commotio Cordis: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Link MS; Estes NA; Maron BJ;
    Circulation; 2015 Dec; 132(22):e339-42. PubMed ID: 26621653
    [No Abstract]   [Full Text] [Related]  

  • 24. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 15: Legal Aspects of Medical Eligibility and Disqualification Recommendations: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Mitten MJ; Zipes DP; Maron BJ; Bryant WJ
    J Am Coll Cardiol; 2015 Dec; 66(21):2447-2450. PubMed ID: 26542663
    [No Abstract]   [Full Text] [Related]  

  • 25. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 9: Arrhythmias and Conduction Defects: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Zipes DP; Link MS; Ackerman MJ; Kovacs RJ; Myerburg RJ; Estes NAM
    J Am Coll Cardiol; 2015 Dec; 66(21):2412-2423. PubMed ID: 26542670
    [No Abstract]   [Full Text] [Related]  

  • 26. There is No Reason to Adopt ECG s and Abandon American Heart Association/American College of Cardiology History and Physical Screening for Detection of Cardiovascular Disease in the Young.
    Maron BJ; Thompson PD; Maron MS
    J Am Heart Assoc; 2019 Jul; 8(14):e013007. PubMed ID: 31286811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Knowledge Gaps in Cardiovascular Care of the Older Adult Population: A Scientific Statement From the American Heart Association, American College of Cardiology, and American Geriatrics Society.
    Rich MW; Chyun DA; Skolnick AH; Alexander KP; Forman DE; Kitzman DW; Maurer MS; McClurken JB; Resnick BM; Shen WK; Tirschwell DL;
    Circulation; 2016 May; 133(21):2103-22. PubMed ID: 27067230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 5: Valvular Heart Disease: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Bonow RO; Nishimura RA; Thompson PD; Udelson JE;
    Circulation; 2015 Dec; 132(22):e292-7. PubMed ID: 26621646
    [No Abstract]   [Full Text] [Related]  

  • 29. Significance of false negative electrocardiograms in preparticipation screening of athletes for hypertrophic cardiomyopathy.
    Rowin EJ; Maron BJ; Appelbaum E; Link MS; Gibson CM; Lesser JR; Haas TS; Udelson JE; Manning WJ; Maron MS
    Am J Cardiol; 2012 Oct; 110(7):1027-32. PubMed ID: 22809754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 4: Congenital Heart Disease: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Van Hare GF; Ackerman MJ; Evangelista JA; Kovacs RJ; Myerburg RJ; Shafer KM; Warnes CA; Washington RL;
    Circulation; 2015 Dec; 132(22):e281-91. PubMed ID: 26621645
    [No Abstract]   [Full Text] [Related]  

  • 31. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 10: The Cardiac Channelopathies: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Ackerman MJ; Zipes DP; Kovacs RJ; Maron BJ;
    Circulation; 2015 Dec; 132(22):e326-9. PubMed ID: 26527716
    [No Abstract]   [Full Text] [Related]  

  • 32. Screening young athletes for prevention of sudden cardiac death: Practical recommendations for sports physicians.
    Chatard JC; Mujika I; Goiriena JJ; Carré F
    Scand J Med Sci Sports; 2016 Apr; 26(4):362-74. PubMed ID: 26432052
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 6: Hypertension: A Scientific Statement from the American Heart Association and the American College of Cardiology.
    Black HR; Sica D; Ferdinand K; White WB;
    Circulation; 2015 Dec; 132(22):e298-302. PubMed ID: 26621647
    [No Abstract]   [Full Text] [Related]  

  • 34. Cardiovascular Screening in Young Athletes: Evidence for the Electrocardiogram.
    Asif IM; Drezner JA
    Curr Sports Med Rep; 2016; 15(2):76-80. PubMed ID: 26963013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 11: Drugs and Performance-Enhancing Substances: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Estes NA; Kovacs RJ; Baggish AL; Myerburg RJ;
    Circulation; 2015 Dec; 132(22):e330-3. PubMed ID: 26621651
    [No Abstract]   [Full Text] [Related]  

  • 36. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 1: Classification of Sports: Dynamic, Static, and Impact: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Levine BD; Baggish AL; Kovacs RJ; Link MS; Maron MS; Mitchell JH;
    Circulation; 2015 Dec; 132(22):e262-6. PubMed ID: 26621643
    [No Abstract]   [Full Text] [Related]  

  • 37. Summaries for patients. Cost-effectiveness of different types of evaluations before sports participation in young athletes.
    Ann Intern Med; 2010 Mar; 152(5):I40. PubMed ID: 20194229
    [No Abstract]   [Full Text] [Related]  

  • 38. Should electrocardiography be used in cardiovascular screening of high school athletes?
    Yarows SA; Smith FA
    Ann Intern Med; 2010 Jul; 153(1):64; author reply 64-5. PubMed ID: 20621918
    [No Abstract]   [Full Text] [Related]  

  • 39. Is there evidence for mandating electrocardiogram as part of the pre-participation examination?
    Borjesson M; Dellborg M
    Clin J Sport Med; 2011 Jan; 21(1):13-7. PubMed ID: 21200165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preparticipation cardiovascular screening in young athletes: current guidelines and dilemmas.
    Seto CK; Pendleton ME
    Curr Sports Med Rep; 2009; 8(2):59-64. PubMed ID: 19276904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.